Enoblituzumab, CAS 1353485-38-7

Product Description: Enoblituzumab (MGA271) is a humanized IgG1κ monoclonal antibody recognizing human B7-H3 protein, a member of the B7 family of immune regulators[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Hińcza-Nowak K, et al. Immune Profiling of Medullary Thyroid Cancer-An Opportunity for Immunotherapy. Genes (Basel). 2021 Sep 28;12(10):1534. /[2]Chapoval, et al. Immune Checkpoints of the B7 Family. Part 2. Representatives of the B7 Family B7-H3, B7-H4, B7-H5, B7-H6, B7-H7, and ILDR2 and Their Receptors. Russ J Bioorg Chem 45, 321–334 (2019). /[3]Loo D, et al. Development of an Fc-enhanced anti-B7-H3 monoclonal antibody with potent antitumor activity. Clin Cancer Res. 2012 Jul 15;18(14):3834-45.

CAS Number: 1353485-38-7

Molecular Weight: N/A

Compound Purity: 99.16

Research Area: Cancer

Solubility: H2O

Target: Others

• Artikelnummer: MEXHY-P9966-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P9966-10
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated